Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$195 Mln
P/E Ratio
--
P/B Ratio
7.28
Industry P/E
--
Debt to Equity
0.17
ROE
-1.71 %
ROCE
-88.15 %
Div. Yield
0 %
Book Value
8.94
EPS
-42.66
CFO
$-623.12 Mln
EBITDA
$-665.52 Mln
Net Profit
$-706.47 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Outset Medical Inc (OM)
| -34.77 | 8.06 | -15.81 | -70.57 | -73.35 | -- | -- |
|
BSE Sensex
| 1.99 | 3.77 | 4.29 | 8.22 | 11.74 | 20.16 | 11.15 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Outset Medical Inc (OM)
| -79.22 | -79.05 | -43.98 | -18.91 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.50 | 10,289.47 | 14.38 | 12.69 | |
| 73.07 | 9,544.04 | 92.52 | 2.52 | |
| 298.25 | 10,728.90 | 773.26 | 1.2 | |
| 117.67 | 14,455.82 | 41.45 | 5.44 |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification,... on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Address: 3052 Orchard Drive, San Jose, CA, United States, 95134 Read more
President, CEO & Chairman
Ms. Leslie L. Trigg
President, CEO & Chairman
Ms. Leslie L. Trigg
Headquarters
San Jose, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Outset Medical Inc (OM) stood at $ 276 Mln as on 31-Dec-24
The share price of Outset Medical Inc (OM) is $10.86 (NASDAQ) as of 24-Apr-2025 16:28 EDT. Outset Medical Inc (OM) has given a return of -73.35% in the last 3 years.
Outset Medical Inc (OM) has a market capitalisation of $ 195 Mln as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Outset Medical Inc (OM) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Outset Medical Inc (OM) and enter the required number of quantities and click on buy to purchase the shares of Outset Medical Inc (OM).
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Address: 3052 Orchard Drive, San Jose, CA, United States, 95134
The CEO & director of Ms. Leslie L. Trigg. is Outset Medical Inc (OM), and CFO & Sr. VP is Ms. Leslie L. Trigg.
There is no promoter pledging in Outset Medical Inc (OM).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,126
|
|
|
1,070
|
|
|
1,049
|
|
|
978
|
| Outset Medical Inc (OM) | Ratios |
|---|---|
|
Return on equity(%)
|
-170.97
|
|
Operating margin(%)
|
-91.14
|
|
Net Margin(%)
|
-112.57
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Outset Medical Inc (OM) was $0 Mln.
$-0.39
(
